These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 19355803)

  • 1. The total economic burden of overactive bladder in the United States: a disease-specific approach.
    Onukwugha E; Zuckerman IH; McNally D; Coyne KS; Vats V; Mullins CD
    Am J Manag Care; 2009 Mar; 15(4 Suppl):S90-7. PubMed ID: 19355803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic impact of overactive bladder syndrome in six Western countries.
    Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
    BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic costs of overactive bladder in the United States.
    Ganz ML; Smalarz AM; Krupski TL; Anger JT; Hu JC; Wittrup-Jensen KU; Pashos CL
    Urology; 2010 Mar; 75(3):526-32, 532.e1-18. PubMed ID: 20035977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current and future burden and cost of overactive bladder in five European countries.
    Reeves P; Irwin D; Kelleher C; Milsom I; Kopp Z; Calvert N; Lloyd A
    Eur Urol; 2006 Nov; 50(5):1050-7. PubMed ID: 16753252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic costs of overactive bladder in Germany.
    Klotz T; Brüggenjürgen B; Burkart M; Resch A
    Eur Urol; 2007 Jun; 51(6):1654-62; discussion 1662-3. PubMed ID: 17161521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related consequences of overactive bladder.
    Wagner TH; Hu TW; Bentkover J; LeBlanc K; Stewart W; Corey R; Zhou Z; Hunt T
    Am J Manag Care; 2002 Dec; 8(19 Suppl):S598-607. PubMed ID: 12516954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study.
    Sexton CC; Coyne KS; Thompson C; Bavendam T; Chen CI; Markland A
    J Am Geriatr Soc; 2011 Aug; 59(8):1465-70. PubMed ID: 21718275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and burden of overactive bladder in the United States.
    Stewart WF; Van Rooyen JB; Cundiff GW; Abrams P; Herzog AR; Corey R; Hunt TL; Wein AJ
    World J Urol; 2003 May; 20(6):327-36. PubMed ID: 12811491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of urgency urinary incontinence in the United States: a systematic review.
    Coyne KS; Wein A; Nicholson S; Kvasz M; Chen CI; Milsom I
    J Manag Care Pharm; 2014 Feb; 20(2):130-40. PubMed ID: 24456314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated cost of overactive bladder in Thailand.
    Prasopsanti K; Santi-Ngamkun A; Pornprasit K
    J Med Assoc Thai; 2007 Nov; 90(11):2316-20. PubMed ID: 18181313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs of urinary incontinence and overactive bladder in the United States: a comparative study.
    Hu TW; Wagner TH; Bentkover JD; Leblanc K; Zhou SZ; Hunt T
    Urology; 2004 Mar; 63(3):461-5. PubMed ID: 15028438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower urinary tract symptoms in women.
    Milsom I
    Curr Opin Urol; 2009 Jul; 19(4):337-41. PubMed ID: 19444118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
    Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
    BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of overactive bladder.
    Milsom I; Stewart W; Thüroff J
    Am J Manag Care; 2000 Jul; 6(11 Suppl):S565-73. PubMed ID: 11183899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National community prevalence of overactive bladder in the United States stratified by sex and age.
    Coyne KS; Sexton CC; Vats V; Thompson C; Kopp ZS; Milsom I
    Urology; 2011 May; 77(5):1081-7. PubMed ID: 21256571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical visits among adults with symptoms commonly associated with an overactive bladder.
    Kim SH; Boye M; Bhattacharyya SK; Coyne K; Dhawan R
    BJU Int; 2006 Mar; 97(3):551-4. PubMed ID: 16469024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women.
    Wennberg AL; Molander U; Fall M; Edlund C; Peeker R; Milsom I
    Eur Urol; 2009 Apr; 55(4):783-91. PubMed ID: 19157689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China.
    Wang Y; Xu K; Hu H; Zhang X; Wang X; Na Y; Kang X
    Neurourol Urodyn; 2011 Nov; 30(8):1448-55. PubMed ID: 21826714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.